Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003574702 | SCV004294930 | uncertain significance | Dilated cardiomyopathy 1II | 2023-08-10 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies have shown that this premature translational stop signal affects CRYAB function (PMID: 25961584). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Pro155Argfs*9) in the CRYAB gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 21 amino acid(s) of the CRYAB protein. Algorithms developed to predict the effect of variants on protein structure and function are not available or were not evaluated for this variant. ClinVar contains an entry for this variant (Variation ID: 16955). This variant is also known as 464ΔCT. This premature translational stop signal has been observed in individual(s) with CRYAB-related conditios (PMID: 14681890). |
OMIM | RCV000018467 | SCV000038749 | pathogenic | Myofibrillar myopathy 2 | 2003-12-01 | no assertion criteria provided | literature only |